Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 26 | History Defined

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

The Guardian - UK

Bayer Says Legal Woes Could Force It To Pull Weedkiller

German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

International Business Times

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Guardian - UK

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Independent UK

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

The Guardian - UK

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

International Business Times

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

Latin Times

Hedge Fund Managers Are Aggressively Buying Biotech Stocks Despite Trump Hinting at Pharma Tariffs

While Donald Trump spared pharma companies from his tariff announcement last week, he revealed yesterday plans to announce tariffs on the industry soon.

International Business Times

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

The Guardian - UK

China, America and pay inject drama into AstraZeneca’s AGM

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year

The Guardian - UK

Painkillers without the addiction? The new wave of non-opioid pain relief

Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

The Guardian - UK

Biotech group warns exit of top FDA vaccine official will ‘erode scientific standards’

Rare admonition from a sector that has largely been silent in the face of the second Trump administration

The Guardian - US

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Potential threat of US tariffs ‘not as stark’ as 2008 crash – Irish minister

Enterprise Minister Peter Burke said pharma tariffs could be ‘a double-edged sword’ for the US administration.

Al Jazeera

Why are users of 23andMe being urged to delete their data?

Genetic testing company’s bankruptcy proceedings could result in auction of the genetic data of 15 million users.

AAP

Banks drag back early gains as local shares edge higher

The Australian share market has given up more than half its early session gains but finished slightly higher, after a dramatic about-face in financials stocks.

The Independent UK

Man who claimed Roundup caused his cancer awarded $2.1billion

The verdict marks the latest in a long-running series of court battles Monsanto has faced over its Roundup herbicide

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

Pharma company will invest money over five years in ‘strategic partnership’ after ditching UK expansion

The Guardian - UK

UK pharmacies could cut hours unless NHS provides ‘new and sufficient’ funding

The National Pharmacy Association has recommended collective action for the first time in its history

Tom’s Hardware

AMD manager reports 45% GPU retail market share in Japan — Eyes 70% as the next target

AMD marketing manager Yoshiaki Sato reported that Radeon GPUs have accounted for 45% of GPU sales in Japan, presumably since RDNA 4 launched.

The Guardian - UK

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

The Guardian - UK

Ireland could lose pharma tax to US after Trump accusations, experts warn

Predictions that US firms could retain manufacturing plants in Ireland but move profits back to America

The Independent UK

CVS is opening more standalone pharmacies after shuttering 1,000 stores

CVS will open a dozen new stores, but they’ll be half the size of a typical location

Tom’s Hardware

Raspberry Pi powers briefcase-sized PiEEG 'Bio Lab' project

Blink twice to control the robot arm

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.